These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20452168)

  • 21. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
    Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients.
    Benoist S; Salabert AS; Penna C; Karoui M; Julié C; Rougier P; Nordlinger B
    Surgery; 2006 Sep; 140(3):396-403. PubMed ID: 16934601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.
    Kishi Y; Zorzi D; Contreras CM; Maru DM; Kopetz S; Ribero D; Motta M; Ravarino N; Risio M; Curley SA; Abdalla EK; Capussotti L; Vauthey JN
    Ann Surg Oncol; 2010 Nov; 17(11):2870-6. PubMed ID: 20567921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of chemotherapy on resection of colorectal liver metastases.
    Pessaux P; Chenard MP; Bachellier P; Jaeck D
    J Visc Surg; 2010 Aug; 147(4):e193-201. PubMed ID: 20655821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.
    Aussilhou B; Dokmak S; Faivre S; Paradis V; Vilgrain V; Belghiti J
    Ann Surg Oncol; 2009 Jun; 16(6):1553-9. PubMed ID: 19363584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
    Yoo PS; Lopez-Soler RI; Longo WE; Cha CH
    Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases.
    Khan AZ; Morris-Stiff G; Makuuchi M
    J Hepatobiliary Pancreat Surg; 2009; 16(2):137-44. PubMed ID: 19093069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases.
    Hubert C; Fervaille C; Sempoux C; Horsmans Y; Humblet Y; Machiels JP; Zech F; Ceratti A; Gigot JF
    Surgery; 2010 Feb; 147(2):185-94. PubMed ID: 20109620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Roles of hepatectomy for colorectal liver metastases with necrotic foci caused by prior anti-cancer therapies].
    Ko S; Mukogawa T; Ishikawa H; Inoue T; Nishiwada T; Nakamoto T; Kunishige T; Watanabe A
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2569-72. PubMed ID: 21224642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases.
    Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Sekido H; Togo S
    Surgery; 2006 May; 139(5):599-607. PubMed ID: 16701091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined portal vein embolization and preoperative chemotherapy prior to liver resection for colorectal cancer metastases.
    Spelt L; Norman P; Törnqvist L; Tingstedt B; Andersson R
    Scand J Gastroenterol; 2012 Sep; 47(8-9):975-83. PubMed ID: 22631611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case with liver resection of metastasis from rectal cancer after FOLFOX4+bevacizumab treatment].
    Kojima T; Matsui T; Uemura T; Fujimitsu Y; Kure N; Kojima H
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1761-3. PubMed ID: 18931584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy's hepatotoxicity: what is the impact on surgery?].
    Pessaux P
    J Chir (Paris); 2010 Jan; 147 Suppl 1():S7-S11. PubMed ID: 20172202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].
    Yoshida Y; Hasegawa J; Nishimura J; Hirota M; Kim Y; Nezu R
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1293-6. PubMed ID: 21829066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.
    Mehta NN; Ravikumar R; Coldham CA; Buckels JA; Hubscher SG; Bramhall SR; Wigmore SJ; Mayer AD; Mirza DF
    Eur J Surg Oncol; 2008 Jul; 34(7):782-6. PubMed ID: 18160247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of liver failure associated with liver damage due to mFOLFOX 6 after resection for multiple liver metastases from colorectal cancer].
    Ishizaki T; Abe T; Koyanagi Y; Katsumata K; Wada T; Tsuchida A; Aoki T
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):945-8. PubMed ID: 17565263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of neo-adjuvant chemotherapy by FOLFOX and FOLFIRI for colorectal liver metastasis].
    Amano R; Yamada N; Noda E; Kubo N; Tanaka H; Muguruma K; Inoue T; Yashiro M; Maeda K; Onoda N; Sawada T; Nakata B; Ohira M; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2003-5. PubMed ID: 20037305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases.
    van der Pool AE; Marsman HA; Verheij J; Ten Kate FJ; Eggermont AM; Ijzermans JN; Verhoef C
    J Surg Oncol; 2012 Dec; 106(7):892-7. PubMed ID: 22552819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
    Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
    Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.
    Rodriguez NA; Ascaso FJ
    J Clin Oncol; 2011 Jun; 29(18):e532-3. PubMed ID: 21483009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.